Biotene OTC Dry Mouth Competitor Remains On Market As GSK Litigates
Executive Summary
Former Biotene owner Laclede ordered by US federal judge to stop using brand, now owned by GSK, to promote its competing line of Salivea dry mouth products. But judge rejected GSK’s request that the Salivea dry mouth product marketers are subject to a lifetime non-compete agreement.
You may also be interested in...
In Brief: Hormel Buys CytoSport, FDA Warns On Drug Claims, Mira Health Consent Decree
Hormel flexes Muscle Milk for protein; Hangover prevention claims are disease claims; Mira Health cannot resume supplement production without FDA permission; Batch production records require details; Laclede needs drug approval for vaginal products and U.S. & Korea ink organic equivalency agreement.
With Biotene Acquisition, Glaxo Tries Again In Dry Mouth Category
GlaxoSmithKline expands its consumer oral care business by acquiring Laclede's Biotene line of dry mouth products
With Biotene Acquisition, Glaxo Tries Again In Dry-Mouth Category
GlaxoSmithKline expands its consumer oral-care business with the acquisition of Laclede's Biotene line of products indicated for dry mouth, or xerostomia